SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 228 filers reported holding SAGE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 2.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,661,687 | -65.0% | 712,424 | -20.0% | 0.01% | -61.5% |
| Q2 2023 | $41,849,821 | -11.3% | 890,043 | -20.9% | 0.01% | -13.3% |
| Q1 2023 | $47,197,363 | +14.3% | 1,124,818 | +3.9% | 0.02% | +7.1% |
| Q4 2022 | $41,307,000 | -3.5% | 1,083,044 | -1.0% | 0.01% | -12.5% |
| Q3 2022 | $42,821,000 | +71.6% | 1,093,477 | +41.6% | 0.02% | +77.8% |
| Q2 2022 | $24,949,000 | -7.6% | 772,356 | -5.3% | 0.01% | +12.5% |
| Q1 2022 | $26,996,000 | -18.5% | 815,621 | +4.8% | 0.01% | -11.1% |
| Q4 2021 | $33,107,000 | +8.8% | 778,322 | +13.3% | 0.01% | -10.0% |
| Q3 2021 | $30,437,000 | -11.4% | 687,032 | +13.6% | 0.01% | -9.1% |
| Q2 2021 | $34,355,000 | +2.7% | 604,941 | +35.3% | 0.01% | 0.0% |
| Q1 2021 | $33,456,000 | -0.7% | 446,954 | +14.7% | 0.01% | -8.3% |
| Q4 2020 | $33,706,000 | +41.5% | 389,634 | -0.1% | 0.01% | +20.0% |
| Q3 2020 | $23,827,000 | +53.8% | 389,996 | +4.7% | 0.01% | +42.9% |
| Q2 2020 | $15,497,000 | -11.2% | 372,616 | -38.8% | 0.01% | -22.2% |
| Q1 2020 | $17,448,000 | -28.8% | 608,714 | +79.1% | 0.01% | -10.0% |
| Q4 2019 | $24,512,000 | -61.6% | 339,925 | -25.3% | 0.01% | -65.5% |
| Q3 2019 | $63,812,000 | -25.0% | 454,835 | -2.1% | 0.03% | -23.7% |
| Q2 2019 | $85,065,000 | +49.6% | 464,623 | +30.0% | 0.04% | +46.2% |
| Q1 2019 | $56,857,000 | +135.8% | 357,483 | +42.0% | 0.03% | +116.7% |
| Q4 2018 | $24,112,000 | -47.9% | 251,754 | -23.7% | 0.01% | -25.0% |
| Q3 2018 | $46,292,000 | -17.8% | 329,837 | -8.4% | 0.02% | -36.0% |
| Q2 2018 | $56,330,000 | +13.8% | 359,941 | +17.1% | 0.02% | +13.6% |
| Q1 2018 | $49,485,000 | +67.7% | 307,315 | +71.6% | 0.02% | +69.2% |
| Q4 2017 | $29,502,000 | +653.9% | 179,107 | +185.3% | 0.01% | +550.0% |
| Q3 2017 | $3,913,000 | -17.2% | 62,785 | +5.8% | 0.00% | 0.0% |
| Q2 2017 | $4,723,000 | +13.1% | 59,336 | +0.9% | 0.00% | 0.0% |
| Q1 2017 | $4,177,000 | +38.1% | 58,784 | -0.8% | 0.00% | 0.0% |
| Q4 2016 | $3,024,000 | -13.0% | 59,242 | -21.5% | 0.00% | 0.0% |
| Q3 2016 | $3,475,000 | +98.6% | 75,464 | +29.9% | 0.00% | +100.0% |
| Q2 2016 | $1,750,000 | +325.8% | 58,092 | +352.7% | 0.00% | – |
| Q1 2016 | $411,000 | -36.4% | 12,832 | +16.0% | 0.00% | – |
| Q4 2015 | $646,000 | -58.0% | 11,066 | -69.5% | 0.00% | -100.0% |
| Q3 2015 | $1,538,000 | -44.2% | 36,311 | -3.8% | 0.00% | -50.0% |
| Q2 2015 | $2,754,000 | +267.2% | 37,728 | +152.7% | 0.00% | – |
| Q1 2015 | $750,000 | – | 14,930 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Integral Health Asset Management, LLC | 409,000 | $17,399,000 | 4.82% |
| Palo Alto Investors LP | 781,730 | $33,255,000 | 2.12% |
| DAFNA Capital Management LLC | 180,306 | $7,670,000 | 1.93% |
| Boxer Capital, LLC | 1,094,000 | $46,539,000 | 1.81% |
| Deep Track Capital, LP | 500,000 | $21,270,000 | 1.50% |
| Bellevue Group AG | 3,228,004 | $137,319,000 | 1.42% |
| EcoR1 Capital, LLC | 940,636 | $40,015,000 | 1.28% |
| Deep Track Capital, LP | 400,000 | $17,016,000 | 1.20% |
| Artal Group S.A. | 1,000,000 | $42,540,000 | 1.15% |
| SECTOR GAMMA AS | 98,904 | $4,207,000 | 0.99% |